Type 3 and 4 are typically for the older age groups. And type 4 is mainly in the adult onset. They do have the ability to walk. However, over time, they may lose their ability to walk and will ...

For children with SMA, assistive devices -- walkers, wheelchairs, standers, and more -- are the key to staying active. Learn which ones may help your child.

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal ...

The first-in-human trial saw all three patients able to increase their walking distance within six minutes to 20 meters.

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

Spinraza (nusinersen) is a prescription drug used to treat spinal muscular atrophy. Spinraza can cause side effects that range from mild to serious. Examples include headache and fever.

A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...

More research is needed to confirm gray matter, the darker tissue found in the brain and spinal cord, “as a potential disease ...

Application is supported by results from the DEVOTE study, which suggested that two doses of Spinraza (nusinerse) 50 mg taken ...

Request To Download Free Sample of This Strategic Report @ Introduction Spinal Muscular Atrophy (SMA) is a rare genetic disorder characterized by the progressive loss of motor neurons, leading to ...